A review of migraine treatment methods: a comparative analysis of therapeutic approaches
DOI:
https://doi.org/10.12775/JEHS.2024.70.55858Keywords
Migraine, migraine treatment, migraine pharmacotherapy, chronic migraine, anti-migraine therapy, migraine prophylaxis, headache, neuromodulation in migraine, serotonin receptors, triptan medications, CGRP inhibitors, CGRP and migraine, non-pharmacological migraine treatmentAbstract
Migraine, a complex neurological disorder, affects a significant portion of the population and presents both medical and societal challenges. The aim of this paper is to provide a detailed review and analysis of available therapeutic methods for patients suffering from migraines, considering both pharmacological and non-pharmacological therapies. The approaches presented include acute treatment with triptans and nonsteroidal anti-inflammatory drugs (NSAIDs), as well as preventive therapies, such as beta-blockers and antiepileptic drugs. The section on non-pharmacological therapies focuses on cognitive-behavioral therapy (CBT), biofeedback, and lifestyle recommendations, including diet and sleep hygiene. A review of the literature indicates that integrating pharmacological and non-pharmacological approaches can significantly improve treatment effectiveness and the quality of life for patients with migraines.
References
Silberstein S. D. (2004). Migraine. Lancet (London, England), 363(9406), 381–391. https://doi.org/10.1016/S0140-6736(04)15440-8
Charles A. (2018). The pathophysiology of migraine: implications for clinical management. The Lancet. Neurology, 17(2), 174–182. https://doi.org/10.1016/S1474-4422(17)30435-0
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002). Migraine--current understanding and treatment. The New England journal of medicine, 346(4), 257–270. https://doi.org/10.1056/NEJMra010917
de Tommaso, M., Guido, M., Libro, G., Losito, L., Difruscolo, O., Puca, F., Specchio, L. M., & Carella, A. (2004). Topographic and dipolar analysis of laser-evoked potentials during migraine attack. Headache, 44(10), 947–960. https://doi.org/10.1111/j.1526-4610.2004.04188.x
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., Ashman, E., & Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society (2012). Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 78(17), 1337–1345. https://doi.org/10.1212/WNL.0b013e3182535d20
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiological reviews, 97(2), 553–622. https://doi.org/10.1152/physrev.00034.2015
Diener, H. C., Montagna, P., Gács, G., Lyczak, P., Schumann, G., Zöller, B., Mulder, L. J., Siegel, J., & Edson, K. (2006). Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia : an international journal of headache, 26(5), 537–547. https://doi.org/10.1111/j.1468-2982.2005.01064.x
Hou, T. W., Yang, C. C., Lai, T. H., Wu, Y. H., & Yang, C. P. (2024). Light Therapy in Chronic Migraine. Current pain and headache reports, 28(7), 621–626. https://doi.org/10.1007/s11916-024-01258-y
Ailani, J., Burch, R. C., Robbins, M. S., & Board of Directors of the American Headache Society (2021). The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache, 61(7), 1021–1039. https://doi.org/10.1111/head.14153
Ha, H., & Gonzalez, A. (2019). Migraine Headache Prophylaxis. American family physician, 99(1), 17–24.
Pleș, H., Florian, I. A., Timis, T. L., Covache-Busuioc, R. A., Glavan, L. A., Dumitrascu, D. I., Popa, A. A., Bordeianu, A., & Ciurea, A. V. (2023). Migraine: Advances in the Pathogenesis and Treatment. Neurology international, 15(3), 1052–1105. https://doi.org/10.3390/neurolint15030067
Tiwari, V., & Agrawal, S. (2022). Migraine and Neuromodulation: A Literature Review. Cureus, 14(11), e31223. https://doi.org/10.7759/cureus.31223
Reffat, N., Pusec, C., Price, S., Gupta, M., Mavrocordatos, P., & Abd-Elsayed, A. (2024). Neuromodulation Techniques for Headache Management. Life (Basel, Switzerland), 14(2), 173. https://doi.org/10.3390/life14020173
Choi, H., & Parmar, N. (2014). The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 21(1), 2–9. https://doi.org/10.1097/MEJ.0b013e3283646e1b
Chen, Y. S., Lee, H. F., Tsai, C. H., Hsu, Y. Y., Fang, C. J., Chen, C. J., Hung, Y. H., & Hu, F. W. (2022). Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis. Nutritional neuroscience, 25(9), 1801–1812. https://doi.org/10.1080/1028415X.2021.1904542
Lipton, R. B., Göbel, H., Einhäupl, K. M., Wilks, K., & Mauskop, A. (2004). Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology, 63(12), 2240–2244. https://doi.org/10.1212/01.wnl.0000147290.68260.11
Vogler, B. K., Pittler, M. H., & Ernst, E. (1998). Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia : an international journal of headache, 18(10), 704–708. https://doi.org/10.1046/j.1468-2982.1998.1810704.x
Burstein, R., Blumenfeld, A. M., Silberstein, S. D., Manack Adams, A., & Brin, M. F. (2020). Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review. Headache, 60(7), 1259–1272. https://doi.org/10.1111/head.13849
Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H. C., Brin, M. F., & PREEMPT Chronic Migraine Study Group (2010). OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache, 50(6), 921–936. https://doi.org/10.1111/j.1526-4610.2010.01678.x
Frampton J. E. (2020). OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use. CNS drugs, 34(12), 1287–1298. https://doi.org/10.1007/s40263-020-00776-8
Ramadan N. M. (2004). Prophylactic migraine therapy: mechanisms and evidence. Current pain and headache reports, 8(2), 91–95. https://doi.org/10.1007/s11916-004-0022-z
Andrasik F. (2004). Behavioral treatment of migraine: current status and future directions. Expert review of neurotherapeutics, 4(3), 403–413. https://doi.org/10.1586/14737175.4.3.403
Chou, D. E., Gross, G. J., Casadei, C. H., & Yugrakh, M. S. (2017). External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy. Neuromodulation : journal of the International Neuromodulation Society, 20(7), 678–683. https://doi.org/10.1111/ner.12623
Barbanti, P., Grazzi, L., Egeo, G., Padovan, A. M., Liebler, E., & Bussone, G. (2015). Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. The journal of headache and pain, 16, 61. https://doi.org/10.1186/s10194-015-0542-4
Pleș, H., Florian, I. A., Timis, T. L., Covache-Busuioc, R. A., Glavan, L. A., Dumitrascu, D. I., Popa, A. A., Bordeianu, A., & Ciurea, A. V. (2023). Migraine: Advances in the Pathogenesis and Treatment. Neurology international, 15(3), 1052–1105. https://doi.org/10.3390/neurolint15030067
Loder, E., & Rizzoli, P. (2018). Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018. Headache, 58 Suppl 3, 218–229. https://doi.org/10.1111/head.13375
Tepper, S. J., Cirillo, J., Kim, E., L'Italien, G., Tweedie, J. M., Lodaya, K., Riley, D., Pathan, F., Antaki, N., Nathanson, B. H., & McAllister, P. (2023). The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression. The journal of headache and pain, 24(1), 54. https://doi.org/10.1186/s10194-023-01587-0
Schwedt T. J. (2009). Neurostimulation for primary headache disorders. Current neurology and neuroscience reports, 9(2), 101–107. https://doi.org/10.1007/s11910-009-0017-6
Aguilar-Shea, A. L., Membrilla Md, J. A., & Diaz-de-Teran, J. (2022). Migraine review for general practice. Atencion primaria, 54(2), 102208. https://doi.org/10.1016/j.aprim.2021.102208
Patwardhan, M., Coeytaux, R. R., Deshmukh, R., & Samsa, G. (2007). What is the impact of physician communication and patient understanding in the management of headache?. Neuropsychiatric disease and treatment, 3(6), 893–897. https://doi.org/10.2147/ndt.s493
Marmura, M. J., Silberstein, S. D., & Schwedt, T. J. (2015). The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache, 55(1), 3–20. https://doi.org/10.1111/head.12499
Goldstein J. (2005). Migraine management. Focus on meeting patients' individual needs. Postgraduate medicine, 117(5 Suppl), 17–25. https://doi.org/10.3810/pgm.05.2005.suppl41.211
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paweł Nojek, Wiktoria Pawlik, Mariusz Zimonczyk, Monika Zawół, Gustaw Błaszczyński, Agnieszka Nowotarska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 68
Number of citations: 0
